MHS
RIGL icon

M Holdings Securities’s Rigel Pharmaceuticals RIGL Stock Holding History

M Holdings Securities’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,000
Closed -$69K – 375
2018
Q4 		$69K Hold
3,000
– – 0.02% 320
2018
Q3 		$96K Buy
+3,000
New +$90.1K 0.03% 344

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

M Holdings Securities's RIGL Position: Q1 2019 in Review

M Holdings Securities sold out of Rigel Pharmaceuticals (RIGL) in Q1 2019, closing a stake of 3,000 shares — an estimated $69K sold.

M Holdings Securities first reported a position in RIGL in Q3 2018 and held it in 2 quarters. The position peaked at $96K in Q3 2018. 131 funds tracked by Wall St. Rank hold RIGL as of Q1 2019.

  • M Holdings Securities reported no remaining Rigel Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • M Holdings Securities sold 3,000 Rigel Pharmaceuticals shares in Q1 2019, an estimated $69K.
  • M Holdings Securities first reported a position in Rigel Pharmaceuticals in Q3 2018 and held it in 2 quarters.
  • M Holdings Securities's Rigel Pharmaceuticals position peaked at $96K in Q3 2018.
  • 131 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2019.

Based on M Holdings Securities's 13F filing for Q1 2019, filed 17 May 2019.